Scott syndrome
Scott Syndrome
Scott Syndrome (pronounced: /skɒt sɪnˈdroʊm/) is a rare, inherited bleeding disorder characterized by a defect in the platelet's ability to promote blood clotting. The syndrome was first described by Dr. William Scott in 1979.
Etymology
The term "Scott Syndrome" is named after Dr. William Scott, who first described the condition in 1979. The word "syndrome" comes from the Greek "σύνδρομον" (sýndromon), meaning "concurrence of symptoms," or "concurrence of runnings."
Definition
Scott Syndrome is a rare bleeding disorder that affects the platelets in the blood. It is characterized by a defect in the platelet's ability to promote blood clotting. This defect is due to an impairment in the process of phosphatidylserine exposure on the platelet surface, which is crucial for the formation of a blood clot.
Symptoms
The main symptom of Scott Syndrome is a prolonged bleeding time, despite normal platelet count and function. Other symptoms may include easy bruising, nosebleeds, and excessive bleeding after surgery or injury.
Diagnosis
Diagnosis of Scott Syndrome is typically made through a series of blood tests, including a platelet function test. Genetic testing may also be used to confirm the diagnosis.
Treatment
There is currently no cure for Scott Syndrome. Treatment is focused on managing symptoms and preventing bleeding episodes. This may include the use of anticoagulant medications and platelet transfusions.
Related Terms
- Bleeding disorder
- Platelets
- Blood clotting
- Phosphatidylserine
- Platelet count
- Nosebleeds
- Blood tests
- Anticoagulant
- Platelet transfusion
External links
- Medical encyclopedia article on Scott syndrome
- Wikipedia's article - Scott syndrome
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski